Issue
Korean Journal of Chemical Engineering,
Vol.40, No.2, 337-343, 2023
Controlled release of quercetin from HPMC/gellan gum hydrogel for inhibiting melanogenesis in murine melanoma cells
Although quercetin inhibits melanogenesis, it is cytotoxic at high concentrations. Recent studies have actively investigated carriers for the controlled release of functional drugs at desired concentrations. In this study, porous hydrogel carriers were prepared using hydroxypropyl methylcellulose (HPMC) and gellan gum for the controlled release of quercetin, which acts as a whitening agent. The physical properties and release characteristics of quercetin from HPMC and gellan gum were measured. In a toxicity test using B16F10 melanoma cells, quercetin decreased cell viability at concentrations above 20 µM. Therefore, we used the HPMC (H)/gellan gum (G) hydrogel with H1/G9, H2/G8, H3/G7, H4/G6, and H5/G5 (w/w) ratios at a final solid content of 4% to control quercetin release at a noncytotoxic level. Stiffness of the hydrogel increased, and the pore size became finer with a higher gellan gum content. Quercetin release rate from the HPMC/gellan gum hydrogel decreased with increasing content of gellan gum; for example, the release rate of quercetin from the H1/G9 hydrogel was approximately half of that from the H5/G5 hydrogel. These results suggest that the HPMC/gellan hydrogel may be a useful delivery vehicle to release quercetin, a whitening agent, at non-cytotoxic concentrations.
[References]
  1. Brenner M, Hearing VJ, Photochem. Photobiol., 84, 539, 2008
  2. Choi MH, Shin HJ, Cosmetics, 3, 18, 2016
  3. Fujii T, Saito M, Biosci. Biotechnol. Biochem., 73, 1989, 2009
  4. Grasdalen H, Smidsrød O, Carbohydr. Polym., 7, 371, 1987
  5. Joshi SC, Materials, 4, 1861, 2011
  6. Kubo I, Kinst-Hori I, J. Agric. Food Chem., 47, 4121, 1999
  7. Lamson DW, Brignall MS, Alternative Medicine Review: A J. Clinical Therapeutics, 5, 196, 2000
  8. Lin JW, Chiang HM, Lin YC, Wen KC, J. Food Drug Anal., 16, 75, 2008
  9. Mitchell K, Ford JL, Armstrong DJ, Elliott PN, Rostron C, Hogan JE, Int. J. Pharm., 66, 233, 1990
  10. Osmałek T, Froelich A, Tasarek S, Int. J. Pharm., 466, 328, 2014
  11. Rendon MI, Gaviria JI, Dermatol. Surg., 31, 886, 2005
  12. Sarkar N, J. Appl. Polym. Sci., 24, 1073, 1979
  13. Siepmann J, Kranz H, Bodmeier R, Peppas N, Pharm. Res., 16, 1748, 1999
  14. Siepmann J, Peppas NA, Adv. Drug Deliv. Rev., 64, 163, 2012
  15. Soppirnath KS, Aminabhavi TM, Eur. J. Pharm. Biopharm., 53, 87, 2002
  16. Srivastava S, Somasagara RR, Hegde M, Nishana M, Tadi SK, Srivastava M, Choudhary B, Raghavan SC, Sci. Rep., 6, 1, 2016
  17. Taïeb A, Cario-André M, Briganti S, Picardo M, Melanins and melanosomes: Biosynthesis, structure, physiological and pathological functions, Wiley-Blackwell, Weinheim, Germany (2011).
  18. Tang Y, Sun J, Fan H, Zhang X, Carbohydr. Polym., 88, 46, 2012
  19. Varghese JS, Chellappa N, Fathima NN, Colloids Surf. B: Biointerfaces, 113, 346, 2014
  20. Wasmeier C, Hume AN, Bolasco G, Seabra MC, J. Cell Sci., 121, 3995, 2008
  21. Yang YM, Son YO, Lee SA, Jeon YM, Lee JC, Phytotherapy Res., 25, 1166, 2011